MCMedicalCodingSoftware
Free trial
3E0F305

3E0F305 — Introduction of Other Antineoplastic into Respiratory Tract, Percutaneous Approach

Billable / specific codeICD-10-PCS

CMS abbreviated title: Introduce Oth Antineoplastic in Resp Tract, Perc

How 3E0F305 is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. 3SectionAdministration — What family of procedure this is
  2. EBody systemWhich system it acts on
  3. 0Root operationThe objective — the verb of the procedure
  4. FBody partThe specific site
  5. 3ApproachHow the site was reached
  6. 0DeviceWhat was left in place, if anything
  7. 5QualifierA further distinction where one applies

Codes near 3E0F305

In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.

  • 3E0E8BZIntroduction of Anesthetic Agent into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E8GCIntroduction of Other Therapeutic Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E8HZIntroduction of Radioactive Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E8KZIntroduction of Other Diagnostic Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E8NZIntroduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E8SFIntroduction of Other Gas into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E8TZIntroduction of Destructive Agent into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0F304Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Percutaneous Approach
  • 3E0F305Introduction of Other Antineoplastic into Respiratory Tract, Percutaneous Approach
  • 3E0F30MIntroduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Percutaneous Approach
  • 3E0F328Introduction of Oxazolidinones into Respiratory Tract, Percutaneous Approach
  • 3E0F329Introduction of Other Anti-infective into Respiratory Tract, Percutaneous Approach
  • 3E0F33ZIntroduction of Anti-inflammatory into Respiratory Tract, Percutaneous Approach
  • 3E0F36ZIntroduction of Nutritional Substance into Respiratory Tract, Percutaneous Approach
  • 3E0F37ZIntroduction of Electrolytic and Water Balance Substance into Respiratory Tract, Percutaneous Approach
  • 3E0F3BZIntroduction of Anesthetic Agent into Respiratory Tract, Percutaneous Approach
  • 3E0F3GCIntroduction of Other Therapeutic Substance into Respiratory Tract, Percutaneous Approach
ICD-10-PCSFY2026